Ambien to lower doses for women, possibly men
May 15, 2013 (CHICAGO) (WLS) -- The popular sleep drug Ambien is getting new labeling due to concerns about residual effects the next day.
The FDA announced new, lower dose labeling for Ambien, which is also known as zolpidem. The goal is to cut down on daytime drowsiness that could be a hazard while performing certain tasks such as driving.
The FDA is asking the manufacturers to cut the recommended doses for women in half and to consider prescribing lower doses for men. Women reportedly eliminate zolpidem more slowly from their bodies.
These changes were spurred by new driving simulation studies showing that current prescribed levels impair alertness the next day.
- Obama urges world to act on Mandela legacy
- Temps dip to 18-year low, more snow on the way
- Evan Lysacek out of Sochi Games due to injury
- ABC7 Weather Forecast
- SNAP: Reaction to Lakeview priest allegations not enough
- Northwest Side fire displaces 5
- Flossmoor fire injures woman
- Evanston attempted sex assault triggers alert
- Bears fans brave frigid temps at Soldier Field
- O'Hare yoga room opening
- Bobby Rush returning to Congress from leave of absence
- Waukegan police search for suspect in sex assault
- Mom wants justice in toddler's dog death
- abcnews: Football player suspended for snowball fight
- 7 in :77